A1EAY
Sulfinpyrazone
| Created: | 2024-08-20 |
| Last modified: | 2025-11-17 |
Find Related PDB Entry |
|---|
Find related ligands: |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 49 |
| Chiral Atom Count | 1 |
| Bond Count | 52 |
| Aromatic Bond Count | 18 |
Chemical Component Summary | |
|---|---|
| Name | Sulfinpyrazone |
| Synonyms | 1,2-diphenyl-4-[2-(phenylsulfinyl)ethyl]pyrazolidine-3,5-dione |
| Systematic Name (OpenEye OEToolkits) | 1,2-diphenyl-4-[2-(phenylsulfinyl)ethyl]pyrazolidine-3,5-dione |
| Formula | C23 H20 N2 O3 S |
| Molecular Weight | 404.482 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | CACTVS | 3.385 | O=C1C(CC[S](=O)c2ccccc2)C(=O)N(N1c3ccccc3)c4ccccc4 |
| SMILES | OpenEye OEToolkits | 2.0.7 | c1ccc(cc1)N2C(=O)C(C(=O)N2c3ccccc3)CCS(=O)c4ccccc4 |
| Canonical SMILES | CACTVS | 3.385 | O=C1C(CC[S@@](=O)c2ccccc2)C(=O)N(N1c3ccccc3)c4ccccc4 |
| Canonical SMILES | OpenEye OEToolkits | 2.0.7 | c1ccc(cc1)N2C(=O)C(C(=O)N2c3ccccc3)CCS(=O)c4ccccc4 |
| InChI | InChI | 1.06 | InChI=1S/C23H20N2O3S/c26-22-21(16-17-29(28)20-14-8-3-9-15-20)23(27)25(19-12-6-2-7-13-19)24(22)18-10-4-1-5-11-18/h1-15,21H,16-17H2 |
| InChIKey | InChI | 1.06 | MBGGBVCUIVRRBF-UHFFFAOYSA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| DrugBank ID | DB01138 |
|---|---|
| Name | Sulfinpyrazone |
| Groups | approved |
| Description | A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties. |
| Synonyms |
|
| Brand Names |
|
| Indication | For the treatment of gout and gouty arthritis. |
| Categories |
|
| ATC-Code | M04AB02 |
| CAS number | 57-96-5 |
Drug Targets
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| Name | Target Sequence | Pharmacological Action | Actions |
|---|---|---|---|
| Solute carrier family 22 member 12 | MAFSELLDLVGGLGRFQVLQTMALMVSIMWLCTQSMLENFSAAVPSHRCW... | unknown | inhibitor |
| Multidrug resistance-associated protein 1 | MALRGFCSADGSDPLWDWNVTWNTSNPDFTKCFQNTVLVWVPCFYLWACF... | unknown | inhibitor |
| ATP-binding cassette sub-family C member 2 | MLEKFCNSTFWNSSFLDSPEADLPLCFEQTVLVWIPLGYLWLLAPWQLLH... | unknown | inhibitor |
| Nuclear receptor subfamily 1 group I member 2 | MEVRPKESWNHADFVHCEDTESVPGKPSVNADEEVGGPQICRVCGDKATG... | unknown | activator |
| Cytochrome P450 2C9 | MDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDI... | unknown | inhibitor |
| View More | |||
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
| Resource Name | Reference |
|---|---|
| Pharos | CHEMBL832 |
| PubChem | 5342 |
| ChEMBL | CHEMBL832 |
| ChEBI | CHEBI:9342 |














